Free Trial

Fresenius SE & Co. KGaA (FSNUY) Stock Price, News & Analysis

+0.20 (+2.61%)
(As of 05/24/2024 ET)
Today's Range
50-Day Range
52-Week Range
17,060 shs
Average Volume
34,373 shs
Market Capitalization
$17.54 billion
P/E Ratio
Dividend Yield
Price Target
FSNUY stock logo

About Fresenius SE & Co. KGaA Stock (OTCMKTS:FSNUY)

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, dialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients. This segment offers I.V. generic drugs; biosimilar drugs for autoimmune diseases and oncology; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The Fresenius Vamed segment provides services for hospitals and other healthcare facilities. This segment also offers operational management of healthcare facilities and provides services to patients. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.

FSNUY Stock Price History

FSNUY Stock News Headlines

Fresenius Raises FY24 Outlook
Fresenius SE & Co. KGaA ADR
Fresenius Medical Care 4Q Net Pft EUR188M
Fresenius SE & Co. KGaA (FSNUY)
See More Headlines
Receive FSNUY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius SE & Co. KGaA and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$24.01 billion
Cash Flow
$2.26 per share
Book Value
$15.07 per share


Outstanding Shares
Free Float
Market Cap
$17.54 billion
Not Optionable

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Michael Sen (Age 56)
    CEO, President & Chairman of Management Board - Fresenius Management SE
    Comp: $4.44M
  • Ms. Sara Lisa Hennicken (Age 44)
    CFO & Member of the Management Board - Fresenius Management SE
    Comp: $1.68M
  • Mr. Pierluigi Antonelli
    Member of Management Board of Fresenius Management SE & CEO of Fresenius Kabi
  • Dr. Michael Sven Moser Ph.D. (Age 46)
    Member of Management Board of Fresenius Management SE
    Comp: $1.3M
  • Mr. Robert Moller (Age 53)
    Member of the Management Board of Fresenius Management SE
    Comp: $1.25M
  • Mr. Markus Georgi
    Senior Vice President of Investor Relations
  • Matthias Link
    Senior Vice President Corporate Communications

FSNUY Stock Analysis - Frequently Asked Questions

Should I buy or sell Fresenius SE & Co. KGaA stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Fresenius SE & Co. KGaA in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" FSNUY shares.
View FSNUY analyst ratings
or view top-rated stocks.

How have FSNUY shares performed in 2024?

Fresenius SE & Co. KGaA's stock was trading at $7.7250 at the beginning of the year. Since then, FSNUY shares have increased by 1.6% and is now trading at $7.85.
View the best growth stocks for 2024 here

Are investors shorting Fresenius SE & Co. KGaA?

Fresenius SE & Co. KGaA saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 85,500 shares, an increase of 129.2% from the April 15th total of 37,300 shares. Based on an average trading volume of 132,600 shares, the short-interest ratio is currently 0.6 days.
View Fresenius SE & Co. KGaA's Short Interest

How were Fresenius SE & Co. KGaA's earnings last quarter?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) released its earnings results on Thursday, May, 6th. The company reported $0.24 EPS for the quarter, topping the consensus estimate of $0.23 by $0.01. The firm earned $10.83 billion during the quarter. Fresenius SE & Co. KGaA had a net margin of 0.71% and a trailing twelve-month return on equity of 4.88%.

Is Fresenius SE & Co. KGaA a good dividend stock?

Fresenius SE & Co. KGaA (OTCMKTS:FSNUY) pays an annual dividend of $0.17 per share and currently has a dividend yield of 2.19%. The dividend payout ratio is 154.56%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, FSNUY will have a dividend payout ratio of 18.09% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FSNUY.

How do I buy shares of Fresenius SE & Co. KGaA?

Shares of FSNUY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:FSNUY) was last updated on 5/25/2024 by Staff

From Our Partners